Progress
0%
Postpartum Thyroiditis
Cause
Autoimmune thyroid destruction
Increased risk with:
Previous episodes of postpartum thyroiditis
Positive thyroid peroxidase (TPO) antibodies
T1DM
Disease Course
Typically 1–6 months postpartum
Hyperthyroid phase:
Transient (1–2 months)
Hypothyroid phase:
May last 4–6 months; can be permanent in ~20% of cases
Management
Hyperthyroid Phase:
Symptomatic relief:
Propranolol 10 mg BD (no role for thionamides unless >1 year)
Hypothyroid Phase:
Treat if symptomatic or TSH >10:
Levothyroxine 50–100 mcg daily
Continue for 6–12 months, then trial cessation and reassess
Monitoring:
Repeat TSH every 4 weeks in the early stages to monitor recovery
After treatment cessation, recheck TSH in 6 weeks
Long-term follow-up: Annual TSH checks due to risk of permanent hypothyroidism
Postpartum Thyroiditis
Cause
Autoimmune-mediated thyroid injury that occurs in the postpartum period
Higher risk in:
Previous postpartum thyroiditis
Positive thyroid peroxidase (TPO) antibodies
Type 1 diabetes mellitus (autoimmune predisposition)
Disease Course
Typically begins 1–3 months postpartum, although may occur up to 6 months
Phases
Hyperthyroid Phase
Often mild and short-lived (1–2 months)
Can present with palpitations, anxiety, weight loss, heat intolerance
Hypothyroid Phase
May last 4–6 months, presenting with fatigue, weight gain, cold intolerance
Some women only experience one phase (isolated hyperthyroidism or hypothyroidism)
Resolution
Usually returns to euthyroid state within 12–18 months postpartum
~20% may develop permanent hypothyroidism
Clinical Presentation
Hyperthyroid Symptoms
Anxiety, palpitations, irritability, tremor, sweating, weight loss
Hypothyroid Symptoms
Fatigue, weight gain, depression, cold intolerance, constipation, dry skin
Management
Monitoring
Check TSH and free T4 at diagnosis, then every 4–6 weeks early on to track progression through phases
After resolution or treatment cessation, recheck TSH in ~6 weeks
Long-term annual TSH recommended due to risk of permanent hypothyroidism
Hyperthyroid Phase
Typically mild and self-limiting
Symptomatic relief with beta-blockers (e.g. propranolol 10–40 mg BD) if palpitations or significant adrenergic symptoms
No routine role for antithyroid drugs (e.g. carbimazole) unless hyperthyroidism persists >1 year or if Graves’ disease is suspected
If clinical or biochemical features suggest Graves’ (ophthalmopathy, very high T3/T4, positive TSH receptor antibodies), obtain radionuclide imaging or TSI testing
Hypothyroid Phase
Treat with levothyroxine if symptomatic or TSH >10 mU/L
Typical starting dose: 50–100 mcg daily, adjusted based on TSH/free T4
Continue for 6–12 months, then attempt cessation and recheck TSH after 6 weeks to determine if thyroid function has normalised
If TSH remains elevated, long-term levothyroxine may be required
Notes & Follow-Up
Women who have experienced postpartum thyroiditis have an increased risk of future thyroid dysfunction, both in subsequent pregnancies and later in life
Educate on recognising symptoms early in postpartum periods
Emphasise the importance of regular follow-up, especially TSH monitoring in future pregnancies or annually if initial postpartum thyroiditis resolves
Suspect postpartum thyroiditis in any new mother with thyroid-related symptoms within 12 months of delivery
Early phase hyperthyroidism often does not require thionamides, but symptomatic control with beta-blockers is helpful
Address hypothyroidism promptly if TSH is significantly elevated or clinical symptoms are problematic
Monitor TSH periodically even after apparent resolution to catch the 20% who develop permanent hypothyroidism
Bookmark Failed!
Bookmark Saved!
